TLSA
Tiziana Life Sciences (TLSA)
$45
About Tiziana Life Sciences (TLSA)
Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in developing therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer’s. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom.
Details
Daily high
$1.54
Daily low
$1.42
Price at open
$1.49
52 Week High
$2.60
52 Week Low
$0.63
Market cap
173.5M
Dividend yield
0.00%
Volume
177,534
Avg. volume
451,106
P/E ratio
-12.77
Tiziana Life Sciences News
Details
Daily high
$1.54
Daily low
$1.42
Price at open
$1.49
52 Week High
$2.60
52 Week Low
$0.63
Market cap
173.5M
Dividend yield
0.00%
Volume
177,534
Avg. volume
451,106
P/E ratio
-12.77